Latest F-1 registration statements

Vistek Limited, a Singapore-based cabling service provider, filed an F-1/A registration statement for its initial public offering on Nasdaq, seeking to raise approximately $5.6 million to expand its fleet, enhance working capital, and repay debt, while navigating significant customer concentration and operational risks.

Standard Lithium Ltd. has filed a universal shelf prospectus to raise up to US$1 billion through various securities offerings to fund its lithium project development and general corporate purposes.

Rezolve AI plc has filed an F-1 registration statement for the resale of up to 20 million ordinary shares by selling security holders, following a recent $50 million PIPE financing and strategic acquisitions of Bluedot and GroupBy, as the company prepares for Q3 2025 commercialization.

Mainz Biomed N.V. is undertaking a best-efforts public offering of up to 1,470,588 ordinary and pre-funded units to raise approximately $2.565 million net, aiming to advance its colorectal and pancreatic cancer screening tests despite ongoing operating losses and significant shareholder dilution.

Charming Medical Limited, a Hong Kong-based provider of TCM-inspired beauty and wellness services, has filed for an initial public offering on the Nasdaq Capital Market, reporting significant revenue and net income growth for fiscal year 2025 while outlining strategic expansion and diversification plans.

Transten Global Group Limited, a fast-growing cross-border supply chain services provider, has filed an amendment to its F-1 registration statement for a Nasdaq initial public offering, revealing a significant revenue increase in 2024 driven by air freight forwarding services, despite a decline in net income and negative operating cash flow.

TechCreate Group Ltd., a Singapore-based technology consultancy, has filed for an initial public offering on the NYSE American, aiming to raise up to $13.2 million to fuel its expansion in real-time payments and cybersecurity solutions across Southeast Asia and globally.

Agencia Comercial Spirits Ltd, a Taiwan-based whisky importer and distributor, has filed an F-1/A registration statement for its initial public offering on the Nasdaq Capital Market, highlighting substantial revenue and net income growth driven by expanding market presence and strategic product diversification.

DarkIris Inc., a Cayman Islands-incorporated mobile game developer and publisher, filed an amended F-1 registration statement for its initial public offering of 1.5 million Class A Ordinary Shares on Nasdaq, highlighting significant revenue growth and a strategic shift of operations to Hong Kong, while also detailing substantial risks related to its dual-class structure and regulatory environment.

Magnitude International Ltd filed Amendment No. 4 to its F-1 registration statement, primarily to update exhibits and the exhibit index, with no changes to the prospectus.

Zi Yun Dong Fang Limited, a Cayman Islands holding company with Hong Kong-based operations, is seeking to raise up to $7.5 million in its initial public offering on Nasdaq, reporting significant revenue growth but also highlighting substantial risks related to its nascent operating history and the evolving regulatory landscape in Hong Kong and mainland China.

Currenc Group Inc. reported a significant increase in net loss and EBITDA loss for Q1 2025, raising substantial doubt about its ability to continue as a going concern, while simultaneously registering a secondary offering of over 50% of its outstanding shares.

Zerolimit Technology Holding Co. Ltd., a Cayman Islands holding company operating through a China-based Variable Interest Entity, filed an amendment to its F-1 registration statement for an initial public offering of up to 2,000,000 ordinary shares at an anticipated price of $4 per share, seeking to list on Nasdaq under the symbol ZDAN.

Diginex Limited, an ESG impact technology firm, announced a significant increase in revenue for fiscal year 2025, alongside major corporate restructuring, a successful IPO, and ambitious plans for global expansion and acquisitions, despite continued operating losses.

Neo-Concept International Group Holdings Limited, a one-stop apparel solution provider, is launching a secondary offering of up to 10 million Class A Ordinary Shares on Nasdaq, following significant revenue and net income growth in 2024.

Nasus Pharma Ltd., a clinical-stage pharmaceutical company, has filed an F-1/A registration statement for an initial public offering of 1.25 million ordinary shares, seeking to raise approximately $9.5 million to fund its intranasal drug development programs, despite reporting substantial accumulated deficits and raising 'substantial doubt' about its ability to continue as a going concern.

South Bow Corporation has filed an amendment to its F-10 registration statement, establishing a base shelf prospectus for up to U.S.$3 billion in various securities over the next 25 months.

Linkage Global Inc. reported a significant increase in net loss for the six months ended March 31, 2025, despite a substantial revenue surge in its new fully managed e-commerce operation services, driven by higher operating expenses and interest costs from recently issued convertible notes.

High Tide Inc. has filed a universal shelf prospectus to raise up to $100 million through various securities, signaling future growth initiatives while navigating significant U.S. federal cannabis illegality and regulatory uncertainties.

Phaos Technology Holdings (Cayman) Limited, a microscopy solutions provider, has filed for an initial public offering on the NYSE American, seeking to raise approximately $11.24 million, despite reporting an 82.7% revenue decrease and a 31.5% increase in net loss for the six months ended October 31, 2024, raising substantial doubt about its ability to continue as a going concern.

Otsaw Limited has filed an amended F-1 registration statement with the SEC, outlining the terms of its upcoming initial public offering, including underwriting agreements and representative warrants.

Hang Feng Technology Innovation Co., Ltd., a Cayman Islands holding company with primary operations in Hong Kong, is seeking to raise $5.5 million in its initial public offering on the Nasdaq Capital Market, following a significant revenue surge and a shift from net loss to profit in 2024.

Can-Fite BioPharma Ltd. filed an amended prospectus for a best-efforts public offering of American Depositary Shares and various warrants, aiming to raise capital for research, development, and general corporate purposes.

ELC Group Holdings Ltd., a Singapore-based manpower service provider, is seeking to raise capital through an initial public offering on Nasdaq, despite recent declines in overall revenue and net income, as it pivots from cleaning services to focus on its core manpower supply and growing software solutions.

J-Star Holding Co., Ltd. filed an Amendment No. 2 to its F-1 Registration Statement, providing details on past unregistered securities issuances and corporate governance provisions related to director indemnification.

Gelteq Limited has filed an amendment to its F-1 registration statement to allow Lincoln Park Capital Fund, LLC to resell up to 4,000,000 ordinary shares, following recent capital raises and debt conversions.

Jeffs Brands Ltd. filed an amended registration statement for the resale of up to 5.25 million ordinary shares by a related party, stemming from a new $100 million convertible promissory note facility, alongside announcing a new CEO and details of recent strategic acquisitions and divestitures.

Zenta Group Company Limited, a Macau-based professional services provider, is seeking to raise $6.75 million in its initial public offering on the Nasdaq Capital Market, shifting its strategic focus towards rapidly growing fintech services following a decline in its traditional industrial park consultation business.

Innocan Pharma Corporation is pursuing a Nasdaq listing and an initial public offering to fund its innovative LPT-CBD drug development for chronic pain and expand its consumer wellness segment.

Can-Fite BioPharma Ltd. has filed an F-1 registration statement to offer up to 4,901,961 American Depositary Shares and accompanying warrants in a best-efforts offering, aiming to raise approximately $4.20 million in net proceeds for research and development and general corporate purposes.